Ben Wolf will moderate the May 16 panel “Medical Device Good Manufacturing Practices (GMPs): Preparing for the Transition to ISO 13485” at this conference hosted by the Food & Drug Law Institute. This session will explore the impact of harmonization on GMPs. Panelists will consider the risk-based and quality-based approaches outlined in ISO 13485 to address compliance management, safety, and the role of individual processes within a company.
For more information, click here.